Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
4.120
-0.400 (-8.85%)
At close: Oct 8, 2025, 4:00 PM EDT
4.190
+0.070 (1.70%)
After-hours: Oct 8, 2025, 6:39 PM EDT
Salarius Pharmaceuticals Market Cap
Salarius Pharmaceuticals has a market cap or net worth of $2.10 million as of October 8, 2025. Its market cap has decreased by -16.01% in one year.
Market Cap
2.10M
Enterprise Value
1.51M
1-Year Change
-16.01%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since January 29, 2015, Salarius Pharmaceuticals's market cap has decreased from $254.50M to $2.10M, a decrease of -99.17%. That is a compound annual growth rate of -36.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 2.30M | -14.81% |
| Dec 31, 2024 | 2.70M | 3.85% |
| Dec 29, 2023 | 2.60M | -25.71% |
| Dec 30, 2022 | 3.50M | -84.38% |
| Dec 31, 2021 | 22.40M | 23.76% |
| Dec 31, 2020 | 18.10M | 17.53% |
| Dec 31, 2019 | 15.40M | 156.67% |
| Dec 31, 2018 | 6.00M | -90.45% |
| Dec 29, 2017 | 62.80M | -33.89% |
| Dec 30, 2016 | 95.00M | -57.44% |
| Dec 31, 2015 | 223.20M | -12.30% |
| Jan 29, 2015 | 254.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |